Literature DB >> 8178948

Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.

L Mazzucchelli1, C Hauser, K Zgraggen, H Wagner, M Hess, J A Laissue, C Mueller.   

Abstract

Interleukin-8 (IL-8) is a potent cytokine for recruitment and activation of neutrophils. To visualize its distribution in the intestinal mucosa and to understand better its possible role in the induction and promotion of inflammatory bowel disease, expression of the IL-8 gene was analyzed in resected bowel segments of 14 patients with active Crohn's disease or ulcerative colitis. In situ hybridization with IL-8 anti-sense RNA probes revealed strong and specific signals in the histologically affected mucosa. The number of cells expressing IL-8 gene correlated with the histological grade of active inflammation. In accordance with the characteristic histological signs of active disease, IL-8-expressing cells were diffusely distributed over the entire affected mucosa in patients with ulcerative colitis, whereas in patients with Crohn's disease, IL-8-expressing cells showed a focal distribution pattern. Cells expressing IL-8 were mainly located at the base of ulcers, in inflammatory exudates on mucosal surfaces, in crypt abscesses, and at the border of fistulae. Analysis of semi-serial sections pointed to macrophages, neutrophils, and epithelial cells as possible sources of this cytokine in active inflammatory bowel disease. We consistently failed to detect IL-8 messenger RNA in the mucosa of uninvolved bowel segments and in normal-appearing control mucosa of patients with colon cancer. In contrast, tissue specimens from two patients with acute appendicitis displayed IL-8-expressing cells in the mucosa. These results support the notion that IL-8 plays and important but nonspecific role in the pathogenesis of inflammatory bowel disease and that the production of IL-8 messenger RNA is restricted to areas with histological signs of inflammatory activity and mucosal destruction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178948      PMCID: PMC1887375     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  42 in total

1.  Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

Authors:  T Yoshimura; K Matsushima; S Tanaka; E A Robinson; E Appella; J J Oppenheim; E J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Induction of mRNA for a serine protease and a beta-thromboglobulin-like protein in mitogen-stimulated human leukocytes.

Authors:  J Schmid; C Weissmann
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

3.  Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.

Authors:  R Eliakim; F Karmeli; E Razin; D Rachmilewitz
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

4.  Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.

Authors:  A Walz; P Peveri; H Aschauer; M Baggiolini
Journal:  Biochem Biophys Res Commun       Date:  1987-12-16       Impact factor: 3.575

5.  Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups.

Authors:  S C Donnelly; R M Strieter; S L Kunkel; A Walz; C R Robertson; D C Carter; I S Grant; A J Pollok; C Haslett
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

6.  Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP).

Authors:  H Gregory; J Young; J M Schröder; U Mrowietz; E Christophers
Journal:  Biochem Biophys Res Commun       Date:  1988-03-15       Impact factor: 3.575

7.  Prostanoid synthesis by cultured intestinal epithelial and mononuclear cells in inflammatory bowel disease.

Authors:  A Zifroni; A J Treves; D B Sachar; D Rachmilewitz
Journal:  Gut       Date:  1983-07       Impact factor: 23.059

8.  Colo-rectal biopsy in inflammatory bowel disease.

Authors:  J H Yardley; M Donowitz
Journal:  Monogr Pathol       Date:  1977

9.  A high proportion of T lymphocytes that infiltrate H-2-incompatible heart allografts in vivo express genes encoding cytotoxic cell-specific serine proteases, but do not express the MEL-14-defined lymph node homing receptor.

Authors:  C Mueller; H K Gershenfeld; C G Lobe; C Y Okada; R C Bleackley; I L Weissman
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  87 in total

1.  Enhanced production of IL-8 in chronic but not in early ileal lesions of Crohn's disease (CD).

Authors:  E Brandt; J F Colombel; N Ectors; L Gambiez; D Emilie; K Geboes; M Capron; P Desreumaux
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 2.  Tumour necrosis factor in mouse models of chronic intestinal inflammation.

Authors:  Christoph Mueller
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  Eosinophil granule-derived major basic protein induces IL-8 expression in human intestinal myofibroblasts.

Authors:  G T Furuta; S J Ackerman; J Varga; A M Spiess; M Y Wang; B K Wershil
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

Review 4.  Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation.

Authors:  J Berkes; V K Viswanathan; S D Savkovic; G Hecht
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

5.  Anti-Inflammatory Effect of Apigenin on LPS-Induced Pro-Inflammatory Mediators and AP-1 Factors in Human Lung Epithelial Cells.

Authors:  Rajeshwari H Patil; R L Babu; M Naveen Kumar; K M Kiran Kumar; Shubha M Hegde; Rashmi Nagesh; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29).

Authors:  O Saitoh; R Matsuse; K Sugi; K Nakagawa; K Uchida; K Maemura; K Kojima; I Hirata; K Katsu
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

Review 7.  Layers of mutualism with commensal bacteria protect us from intestinal inflammation.

Authors:  C Mueller; A J Macpherson
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

8.  Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis.

Authors:  Y Nishio; T Ando; O Maeda; K Ishiguro; O Watanabe; N Ohmiya; Y Niwa; K Kusugami; H Goto
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

9.  Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression.

Authors:  C G Murphy; J N Glickman; K Tomczak; Y Y Wang; A H Beggs; M W Shannon; B H Horwitz
Journal:  Mucosal Immunol       Date:  2008-07       Impact factor: 7.313

10.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.